... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Diffuse large B-cell lymphoma Phase II study Non-Hodgkin’s lymphoma...

...Reena Nair; Neeraj Arora; Mohandas K. Mallath Non-Hodgkin's lymphoma (NHL) is a common hematological malignancy. The age-adjusted incidence rates for NHL in men and women in India are 2.9/100,000 and 1.5/100,000, respectively. These are about one fourth of the incidence rates reported from Western...

... of treatment and achievement of CR are additional important prognostic factors. Dose intensity should not be automatically reduced at the beginning of the treatment, especially now that growth factors are available. 30 6 2009 Non-Hodgkin’s lymphoma Age Prognostic factors Dose intensity...

...E. Salminen; V. Nikkanen; L. Lindholm Goals of Work: There is a need for an effective and nontoxic chemotherapy for palliative indication in non-Hodgkin’s lymphoma (NHL) patients who relapse after conventional or high-dose chemotherapy. The aim of this study was to investigate the feasibility...

... : Prognostic factors in aggressive malignant lymphomas: Description and validation o f a prognostic in­ dex that could identify patients requiring a more intensive therapy. J Clin Oncol 1991:9: 211-219. 4 The International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non...

..., instructions or products referred to in the content or advertisements. Non-Hodgkin’s lymphoma Gastric neoplasm Treatment Survival Original Paper Oncology 1994;51:270-272 Svetislav Jelica Vladimir Kovöina Vesna Jovanovicb Miroslav Opric3 Nenad Milanovica Institute for Oncology and Radiology...

...László Kopper; Ágnes Bánkfalvi; János Földi; Rudolf Mihalik; Mariann Magyar; Ágnes Aczél Chromosomal analysis of three human non-Hodgkin’s lymphoma (NHL) xenografts revealed common extra 14q+ segment and other individual clonal markers without involvement of immunoglobulin light-chain regions. Two...

... lymphoma Non-Hodgkin’s lymphoma Oncology 1991:48:48 53 Diffuse Well Differentiated Lymphocytic Lymphoma: A Clinical Study of 22 Patients' David J. Adelstein, Maria B. Henry, Lynda S. Bowman, John D. Hines Department of Medicine. Division o f Hematology/Oncology. Cleveland Metropolitan General Hospital...

.... Non-Hodgkin’s lymphoma Waldeyer’s ring Combined-modality therapy Oncology 1991:48:362-364 < 1991 S. Karger AG, Basel 0030 2414 91 0485 0362 S 2.75 0 Combined Chemotherapy and Radiotherapy for Lymphomas of Waldeyer s Ring Raymond Liang\ Edmond Cltiw', David Todda , T.K. Chana , Damon Choyb, S.L...

...Federico L. Ampil Twelve patients with untreated malignant lymphoma presenting in the retroperitoneum are reported. The mean age was 52 years. Pain and a palpable mass were the common symptoms. The high and intermediate grade non-Hodgkin’s lymphoma types comprised more than half of the observed...

...Bela Mehta; Suresh Advani; Jayshree Nadkarni Non-Hodgkin’s lymphoma (NHL) patients classified according to the Rappaport classification system had depressed natural killer (NK) and NK cytotoxic factor activities, antibody-dependent cellular cytotoxicity, active killing potential as well...

...Toshiyuki Takagi; Chikara Sakai; Masao Oguro Twenty-eight patients with non-Hodgkin’s lymphoma (NHL) were treated with a combination of (2XXX- R )-4′- o -tetrahydropyranyladriamycin (pirarubicin, THP), cyclophosphamide, vincristine, and prednisolone (VEP-THP therapy). Eleven (45.8%) of twenty-four...

...Michele Di Stasi; Luigi Cavanna; Fabio Fornari; Giuseppe Civardi; Sandro Rossi; Giorgio Sbolli; Marcello Giacani; Salvatore Fermi; Luigi Buscarini Four patients with hepatocellular carcinoma (HCC) out of a group of 132 with non-Hodgkin’s lymphoma (NHL) are described. HCC was the most common second...

...Daniel A. Vorobiof; Aletta P. S. Terblanche; Carla I. Falkson; Geoffrey Falkson Twenty-two patients with histologically confirmed non-Hodgkin’s lymphoma received treatment with a chemotherapy combination containing cyclophosphamide, mitoxantrone, vincristine and prednisone. Leukopenia, nausea...

... and barium meal suggested the presence of a gastric tumour, which was surgically removed and showed the histological features of a non-Hodgkin’s lymphoma, lympho-histiocytic type. Only moderate chemotherapy was given after the operation and the patient obtained a new complete remission which has lasted 3...

... immunofluorescence. In 8 cases the tissue specimens were also assayed for Epstein-Barr virus (EBV) DNA by nucleic acid hybridization. Serum samples of patients and controls were tested for EBV-related antibodies. The histological tests in 37 cases showed a malignant non-Hodgkin lymphoma, and in 23 cases a reactive...

...G. Hœrni-Simon; J.P. Suchaud; H. Eghbali; J.M. Coindre; B. Hœrni Of 498 patients with non-Hodgkin’s lymphoma (NHL), 30 showed secondary central nervous system (CNS) involvement. Of these 30 patients, 26 had high-grade malignancy and 21 lymphoblastic lymphoma, mainly convoluted (n = 8) or Burkitt (n...

..., quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Epidoxorubicin Acute Leukaemia Non-Hodgkin’s lymphoma Oncology 41: 383-386...

...K. Aozasa; H. Nara; H. Ikeda; N. Masaki; Y. Miyata; F. Matsuzuka; Y. Shigematsu Since the Rappaport classification provides little information for the prognosis of extranodal non-Hodgkin’s lymphoma (NHL), the Kiel classification was used for 71 patients with head and neck extranodal NHL, stages IE...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Non-Hodgkin’s lymphoma Hodgkin’s disease Second malignancies Oncology 39: 216-217 (1982) Non-Hodgkin s Lymphoma after Treatment for Hodgkin s...